In vivo osteoarthritis target validation utilizing genetically-modified mice.

Abstract excerpt

Osteoarthritis (OA) is a progressive disease of cartilage degradation that significantly impacts quality of life. There are currently no effective treatments and, while a large number of potential therapeutic targets exist, most have not been validated in vivo. The range of OA models in the mouse has dramatically expanded in the last decade, beyond spontaneous models, to include genetically modified transgenic,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to ADAM Proteins
• Share to Disease Models, Animal
• Share to Growth Hormone